1. Home
  2. CTSO vs AGMH Comparison

CTSO vs AGMH Comparison

Compare CTSO & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • AGMH
  • Stock Information
  • Founded
  • CTSO 1997
  • AGMH 2015
  • Country
  • CTSO United States
  • AGMH Hong Kong
  • Employees
  • CTSO N/A
  • AGMH N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • AGMH EDP Services
  • Sector
  • CTSO Health Care
  • AGMH Technology
  • Exchange
  • CTSO Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • CTSO 51.6M
  • AGMH 18.2M
  • IPO Year
  • CTSO N/A
  • AGMH 2018
  • Fundamental
  • Price
  • CTSO $1.08
  • AGMH $0.12
  • Analyst Decision
  • CTSO Strong Buy
  • AGMH
  • Analyst Count
  • CTSO 3
  • AGMH 0
  • Target Price
  • CTSO $4.67
  • AGMH N/A
  • AVG Volume (30 Days)
  • CTSO 159.7K
  • AGMH 42.0M
  • Earning Date
  • CTSO 05-08-2025
  • AGMH 03-25-2025
  • Dividend Yield
  • CTSO N/A
  • AGMH N/A
  • EPS Growth
  • CTSO N/A
  • AGMH N/A
  • EPS
  • CTSO N/A
  • AGMH N/A
  • Revenue
  • CTSO $37,739,531.00
  • AGMH $64,998,081.00
  • Revenue This Year
  • CTSO $9.20
  • AGMH N/A
  • Revenue Next Year
  • CTSO $11.64
  • AGMH N/A
  • P/E Ratio
  • CTSO N/A
  • AGMH N/A
  • Revenue Growth
  • CTSO 1.80
  • AGMH N/A
  • 52 Week Low
  • CTSO $0.70
  • AGMH $0.08
  • 52 Week High
  • CTSO $1.61
  • AGMH $2.19
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 45.16
  • AGMH 21.86
  • Support Level
  • CTSO $0.99
  • AGMH $0.12
  • Resistance Level
  • CTSO $1.15
  • AGMH $0.29
  • Average True Range (ATR)
  • CTSO 0.08
  • AGMH 0.08
  • MACD
  • CTSO -0.02
  • AGMH -0.01
  • Stochastic Oscillator
  • CTSO 10.53
  • AGMH 6.33

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: